Abstract

Changing patterns of administration of adjuvant chemotherapy for stage I uterine leiomyosarcoma: What is the impact of chemotherapy on disease-free and overall survival? R.D. Littell, L.Y. Tucker, T.R. Raine-Bennett, J.R. Embry-Schubert, E.F. Zaritsky, T.E. Palen, S.E. Lentz. Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA, USA, Kaiser Permanente, Division of Research, Oakland, CA, USA, Colorado Permanente Medical Group, Denver, CO, USA, Kaiser Permanente Medical Center, Oakland, CA, USA, Southern California Permanente Medical Group, Los Angeles, CA, USA

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call